One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
Saved in:
| Title: | One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. |
|---|---|
| Authors: | Henry O; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: ouzama.n.henry@gsk.com., Brzostek J; Poradnia Chorób Zakaźnych ZOZ Dębica, Dębica, Poland. Electronic address: jerzy_br@poczta.onet.pl., Czajka H; Infectious Diseases Outpatient Clinic, The St. Luis Provincial Specialist Children's Hospital, Cracow, Poland. Electronic address: hanna.czajka@onet.pl., Leviniene G; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: giedralev@gmail.com., Reshetko O; Pharmacology, Saratov Medical University, Saratov, Russia. Electronic address: reshetko@yandex.ru., Gasparini R; Department of Health Sciences, Genoa University, Genoa, Italy. Electronic address: gasparini@unige.it., Pazdiora P; Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic. Electronic address: PAZDIORA@fnplzen.cz., Plesca D; Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania. Electronic address: doinaplesca@yahoo.com., Desole MG; Servizio di Igiene Pubblica, ASL Sassari, Italy. Electronic address: madesole@aslsassari.it., Kevalas R; Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: rimantas.kevalas@kaunoklinikos.lt., Gabutti G; Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: giovanni.gabutti@unife.it., Povey M; Biostatistics, GSK, Wavre, Belgium. Electronic address: michael.x.povey@gsk.com., Innis B; Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: innisb00@gmail.com. |
| Source: | Vaccine [Vaccine] 2018 Jan 08; Vol. 36 (3), pp. 381-387. Date of Electronic Publication: 2017 Dec 07. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
